Fedratinib hydrochloride hydrate, CAS [[1374744-69-0]]

Produktübersicht

• Artikelname: Fedratinib hydrochloride hydrate, CAS [[1374744-69-0]]
• Artikelnummer: BYT-ORB1298242
• Hersteller Artikelnummer: orb1298242
• Alternativnummer: BYT-ORB1298242-1, BYT-ORB1298242-10, BYT-ORB1298242-100, BYT-ORB1298242-200, BYT-ORB1298242-25, BYT-ORB1298242-5, BYT-ORB1298242-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: anti-proliferation, Apoptosis, anti-cancer, Inhibitor, FLT3, Fedratinib hydrochloride, Fedratinib hydrochloride Hydrate, Fedratinib hydrochloride hydrate, orally, inhibit, JAK2, JAK, JAK2V617F, JAK2 (V617F), Janus kinase, myeloproliferative, phosphorylation, RET, SAR 302503 hydrochloride, SAR 302503 hydrochloride hydrate, SAR 302503 hydrochloride Hydrate, TG-101348 hydrochloride, TG-101348 hydrochloride hydrate, TG-101348 hydrochloride Hydrate, STAT5

Produktbeschreibung

Fedratinib hydrochloride hydrate is an orally bioavailable, selective, and ATP-competitive small molecule inhibitor of JAK2. It is widely used in preclinical research to investigate myeloproliferative neoplasms, demonstrating activity in both cellular assays and animal models of disease.

Produkteigenschaften

• Molekulargewicht: 615.61
• Reinheit: 99.87% (May vary between batches)
• CAS Nummer: [1374744-69-0]
• Formel: C27H40Cl2N6O4S
• Target-Kategorie: JAK,Apoptosis

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:120 mg/mL (194.93 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (6.5 mM),H2O:97 mg/mL (157.57 mM)